Kenvue Inc. (NYSE:KVUE) Shares Bought by TCW Group Inc.

TCW Group Inc. raised its position in Kenvue Inc. (NYSE:KVUE) by 2.6% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 24,328 shares of the company’s stock after acquiring an additional 621 shares during the quarter. TCW Group Inc.’s holdings in Kenvue were worth $519,000 at the end of the most recent quarter.

Several other large investors also recently bought and sold shares of KVUE. AMF Tjanstepension AB grew its position in Kenvue by 187.3% in the third quarter. AMF Tjanstepension AB now owns 120,477 shares of the company’s stock valued at $2,787,000 after acquiring an additional 78,540 shares in the last quarter. Signaturefd LLC grew its position in Kenvue by 394.0% in the third quarter. Signaturefd LLC now owns 4,061 shares of the company’s stock valued at $94,000 after acquiring an additional 3,239 shares in the last quarter. International Assets Investment Management LLC grew its position in Kenvue by 1,529.5% in the third quarter. International Assets Investment Management LLC now owns 106,341 shares of the company’s stock valued at $2,460,000 after acquiring an additional 99,815 shares in the last quarter. Allworth Financial LP grew its position in Kenvue by 5.9% in the third quarter. Allworth Financial LP now owns 20,023 shares of the company’s stock valued at $463,000 after acquiring an additional 1,113 shares in the last quarter. Finally, Mirae Asset Global Investments Co. Ltd. boosted its stake in shares of Kenvue by 143.0% during the 3rd quarter. Mirae Asset Global Investments Co. Ltd. now owns 293,310 shares of the company’s stock valued at $6,822,000 after buying an additional 172,596 shares during the last quarter. Institutional investors and hedge funds own 97.64% of the company’s stock.

Analyst Ratings Changes

Several equities analysts have recently commented on KVUE shares. Piper Sandler increased their target price on Kenvue from $24.00 to $27.00 and gave the company an “overweight” rating in a research note on Monday. Canaccord Genuity Group reduced their target price on Kenvue from $27.00 to $24.00 and set a “buy” rating for the company in a research note on Friday, February 7th. UBS Group reduced their target price on Kenvue from $23.00 to $21.00 and set a “neutral” rating for the company in a research note on Friday, February 7th. Deutsche Bank Aktiengesellschaft cut Kenvue from a “buy” rating to a “hold” rating and reduced their target price for the company from $25.00 to $24.00 in a research note on Thursday, December 12th. Finally, Royal Bank of Canada reiterated a “sector perform” rating and set a $24.00 target price on shares of Kenvue in a research note on Monday, February 3rd. One research analyst has rated the stock with a sell rating, eight have assigned a hold rating and five have given a buy rating to the company’s stock. According to MarketBeat, the stock has an average rating of “Hold” and a consensus target price of $23.08.

Kenvue Price Performance

Kenvue stock opened at $23.33 on Tuesday. The company has a debt-to-equity ratio of 0.66, a quick ratio of 0.69 and a current ratio of 1.00. The firm has a market cap of $44.72 billion, a P/E ratio of 44.01, a P/E/G ratio of 2.62 and a beta of 1.45. The business’s fifty day moving average is $21.33 and its two-hundred day moving average is $22.21. Kenvue Inc. has a 52 week low of $17.67 and a 52 week high of $24.46.

Kenvue (NYSE:KVUE) last posted its quarterly earnings data on Thursday, February 6th. The company reported $0.26 EPS for the quarter, hitting analysts’ consensus estimates of $0.26. Kenvue had a return on equity of 20.97% and a net margin of 6.66%. Equities research analysts forecast that Kenvue Inc. will post 1.14 earnings per share for the current fiscal year.

Kenvue Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, February 26th. Investors of record on Wednesday, February 12th will be issued a $0.205 dividend. The ex-dividend date is Wednesday, February 12th. This represents a $0.82 dividend on an annualized basis and a yield of 3.52%. Kenvue’s dividend payout ratio is presently 154.72%.

Kenvue Profile

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.